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Abstract
Background: Whey acidic protein (WAP) is a major protein identified in the milk of several mammalian species
with cysteine-rich domains known as four-disulfide cores (4-DSC). The organization of the eutherian WAP genes is
highly conserved through evolution. It has been proposed that WAP could play an important role in regulating the
proliferation of mammary epithelial cells. A bacteriostatic activity was also reported. Conversely to the other
mammalian species expressing WAP in their milk, camel WAP contains 4 additional amino acid residues at the
beginning of the second 4-DSC domain, introducing a phosphorylation site. The aim of this study was to elucidate
the origin of this specificity, which possibly impacts its physiological functions.
Results: Using LC-ESI-MS, we identified in Camelus bactrianus from Kazakhstan a phosphorylated whey protein,
exhibiting a molecular mass (12,596 Da), 32 Da higher than the original WAP (12,564 Da) and co-eluting with WAP.
cDNA sequencing revealed a transition G/A, which modifies an amino acid residue of the mature protein (V12 M),
accounting for the mass difference observed between WAP genetic variants. We also report the existence of two
splicing variants of camel WAP precursors to mRNA, arising from an alternative usage of the canonical splice site
recognized as such in the other mammalian species. However, the major camel WAP isoform results from the
usage of an unlikely intron cryptic splice site, extending camel exon 3 upstream by 12-nucleotides encoding the 4
additional amino acid residues (VSSP) in which a potentially phosphorylable Serine residue occurs. Combining
protein and cDNA sequences with genome data available (NCBI database), we report another feature of the camel
WAP gene which displays a very rare GC-AG type intron. This result was confirmed by sequencing a genomic DNA
fragment encompassing exon 3 to exon 4, suggesting for the GC donor site a compensatory effect in terms of
consensus at the acceptor exon position.
Conclusions: Combining proteomic and molecular biology approaches we report: the characterization of a new
genetic variant of camel WAP, the usage of an unlikely intron cryptic splice site, and the occurrence of an extremely
rare GC-AG type of intron.
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Background
Camel milk is characterized by a high content of vitamin
C (average content ranging between 50 and 250 mg/L),
and endowed with a unique composition of protein
components [1–3]. Its protein content (35–50 g/L) is ra-
ther high [4], with ca. 80% are caseins and 20% whey
proteins that are soluble at pH 4.6 whereas caseins pre-
cipitate close to this pH. The casein fraction comprises 4
caseins (αs1-, αs2-, β- and κ-casein) encoded by four
autosomal genes (CSN1S1, CSN1S2, CSN2 and CSN3, re-
spectively) mapped on chromosome 6 in cattle and goat
[5, 6]. This fraction is rather complex with many splicing
variants and post-translational modifications [3]. Whey
proteins of camel milk mainly consist of α-lactalbumin
(α-LA), glycosylation-dependent cell adhesion molecule
1 (GlyCAM1) or lactophorin which is closely related to
the bovine proteose peptone component 3 (PP3), the in-
nate immunity Peptido Glycan Recognition Protein
(PGRP) and the Whey Acidic Protein (WAP).
WAP is a major whey protein identified in the milk of
several species from eutherians as well as marsupial and
monotremes [7]. It was first shown to be secreted in ro-
dent milks [8], and a whey protein, rich in half-cystine
residues (n = 16), showing strong similarities with ro-
dents WAPs was characterized two years later in camel
milk [9]. Then, the WAP has been identified in rabbits
[10], porcine [11], wallaby [12], brushtail possum [13]
and more recently in canine [14] milks. Camel WAP
reaches an average concentration (157mg/L) 10-folds
lower than that (1500 mg/L) in rodents milk [15],
whereas it is a hundred times higher (15 g/L) in rabbit
milk [16]. Whey acidic protein (WAP) is expressed in
the mammary gland under an extracellular matrix and
lactogenic hormones regulation [17]. WAP gene expres-
sion is induced by prolactin, inhibited by progesterone,
and strongly amplified by glucocorticoids [18].
The overall organization of the eutherian WAP genes
is highly conserved through evolution [7, 19]. It is com-
posed of 4 exons: E1, E3, E4 and E6 (Fig. 1). While the
size of each exon remains rather conserved between spe-
cies, intron size varies considerably. The first exon en-
codes the 5’-UTR, N-terminal signal peptide of 19 aa
residues, and the first 8–10 aa residues of mature eu-
therian proteins. Exons 3 and 4 encode two cysteine-rich
domains (DI and DIIA) known as four-disulfide cores
(4-DSC) in eutherian species [8]. A third domain (DIII)
encoded by exon 2 (missing in eutherian genes) is found
in Monotrema and Marsupial species [7]. Exon 6 en-
codes the last 5–9 aa residues and the 3’-UTR while
exon 5 (DIIB) is only used in Platypus and Marsupial
species [7]. Even though, the promoter region of WAP
gene is similar to house-keeping genes with weak or ab-
sent TATA signal [15], WAP is not found in all euther-
ian milks. The functionality of the gene encoding WAP
Fig. 1 Multiple sequences alignment of WAP among Eutherian species including camel (NCBI, LOC105095719), pig (O46655), dog (GenBank
AAEX02035361, positions 25,184-23,606), rabbit (P09412), rat (G3 V718), and mouse (Q7M748). Four exons: E1, E3, E4 and E6 (numbering of the
putative ancestral gene, proposed by [7], are given in black boxes. Exons 3 and 4 represent 4-DSC domains (DI and DIIA), while exons 1 and 6
indicate the signal peptide (SP) with the N-terminal part (N-ter) of the mature protein and the C-terminal part (C-ter) of the protein, respectively.
WAP motifs are boxed in pink. Conserved Cysteine residues (C) in each 4-DSC domain are pink shaded. Residues identical in more than 3 animal
species are grey shaded. Gaps are introduced to maximize similarities. Tetrapeptide VSSP, that is specific to camel WAP, is highlighted in yellow
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has been lost in ruminants and primates due to a frame-
shift mutation [20]. Consequently, there is no WAP in
the milk of ruminants and primates.
The presence of 4-DSC domains in cysteine-rich pro-
teins led to their classification as the WAP gene family.
Proteins containing WAP domains with a characteristic
4-DSC occur not only in mammals but also in birds, rep-
tiles, amphibians and fish [21]. Each domain comprises
eight cysteine residues with a core of six spatially con-
served, while the remaining two are positioned at variable
distances amino terminal from the core [22].
The sequence conservation of 4-DSC motifs across spe-
cies is significant, and it seems likely that the region may be
involved in the biological function of the molecule. WAPs
share structural similarity with serine protease inhibitors
containing WAP motif domains characterized by a
four-disulfide core (4-DSC) [8]. Possible physiological func-
tions of WAP have been proposed, based on its similarity to
protease inhibitor [16]. Using in vitro and in vivo systems,
Nukumi et al. [23] suggested that WAP plays an important
role in regulating the proliferation of mammary epithelial
cells by preventing elastase-type serine proteases from car-
rying out extracellular matrix laminin degradation. In
addition, the same authors report a bacteriostatic activity of
rat WAP against Staphylococcus aureus [24]. In marsupial,
Sharp et al. [7] suggest that WAP may play also a role in the
development of the young. WFDC2, a second WAP-like
protein, is differentially expressed in the mammary gland of
the tammar wallaby and provides immune protection to the
mammary gland and the developing pouch young [25].
The present study was undertaken first to search for
WAP genetic polymorphism in camel species (Camelus
bactrianus and Camelus dromedarius) from Kazakhstan.
The alignment of sequences of WAP from 5 Eutherian
species in which the WAP gene is expressed reveals the
occurrence of an additional sequence of 4 amino acid
residues in the camel WAP (Fig. 1). We show that this
insertion is due to the usage of an intron cryptic splice
site. Finally, results reported here clarify discrepancies
and erroneous data found in sequence databases (pre-
dicted sequence from genomic data) and literature. We
also report that in camel, the gene encoding WAP com-
prises a rare GC-AG intron-type that represents less
than 1% of annotated donor sites, which is at the origin
of predicted sequence anomalies.
Methods
Milk sample collection and preparation
Raw milk samples were collected during morning milk-
ing on healthy dairy camels (n = 179) that belonged to
two species: C. bactrianus (n = 72) and C. dromedarius
(n = 65), and their hybrids (n = 42) at different lactation
stages, ranging between 30 and 90 days postpartum.
Those milk samples were skimmed as previously
described [3] and skimmed milks and fat were stored at
− 20 °C and − 80 °C, respectively, until analysis.
Selection of Milk samples for analysis
A set of 58 milk samples, including individuals from each
camel species and grazing regions, was selected, based on
lactation stages and number of parities (from 2 to 14), for
SDS-PAGE analysis. Then, eight (C. bactrianus, n = 3, C.
dromedarius, n = 3, and hybrids, n = 2) of those 58 milk
samples from three different regions exhibiting the most
representative profiles were analyzed by LC-MS/MS
(LTQ-Orbitrap Discovery, Thermo Fisher) after tryptic di-
gestion of excised gel bands. Additionally, 30 milk samples
(C. bactrianus, n = 10; C. dromedarius, n = 10; hybrids, n =
10), taken from the 58 milks analyzed by SDS-PAGE, were
analyzed by LC-ESI-MS (Bruker Daltonics). One camel
milk sample (C. bactrianus) displaying a WAP genetic poly-
morphism in LC-ESI-MS was selected for amplification of
WAP cDNA by RT-PCR and cDNA sequencing.
Milk fat globule collection - RNA extraction and single-
Strand cDNA synthesis
Total RNA was extracted from milk fat globules (MFG)
fraction stored at − 80 °C using LS Trizol (Invitrogen) fol-
lowing the protocol from the manufacturer, as described
by Brenaut et al. [26]. Then, first-strand cDNA was syn-
thesized as described [3]. One microliter of 2 U/μL RNase
H (Invitrogen Life Technologies) was then added to re-
move RNA from heteroduplexes. Single-strand cDNA
thus obtained was stored at − 20 °C.
Genomic DNA isolation
Genomic DNA (gDNA) was isolated from fresh blood of C.
dromedarius collected in EDTA using the Wizard® Gen-
omic DNA Purification Kit (Promega Corporation, Madi-
son, USA). Briefly, for 3mL blood sample volume, 9mL of
Cell Lysis Solution was added and centrifuged at 2000 x g
for 10min at room temperature (RT), after incubating the
mixture for 10min, at RT. The supernatant was removed
and, 3mL of Nuclei Lysis Solution was added to the resus-
pended white pellet containing white blood cells. The solu-
tion was pipeted 5-6 times to lyse the white blood cells.
Then, 1mL of Protein Precipitation Solution was added to
the nuclear lysate, and centrifuged at 2000 x g for 10min,
at RT. The supernatant was transferred to a 15 mL tube
containing 3mL isopropanol and centrifuged at 2000 x g
for 1min, at RT. Gently mix the solution and centrifuged at
2000 x g for 1min, at RT. After decanting the supernatant,
one sample volume of 70% ethanol was added to the DNA.
After 1 min centrifugation at 2000 x g, the ethanol was as-
pirated using a drawn Pasteur pipette and the pellet was
air-dried for 10–15min. DNA was rehydrated by adding
250 μL of DNA Rehydration Solution and incubated at 65 °
C for 1 h and stored at 4 °C.
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PCR amplification and DNA sequencing
cDNA and gDNA samples were amplified using pri-
mer pairs, of which sequences are given in Table 1,
designed starting from the published Camelus gene
sequence (NCBI, LOC105095719) and synthesized by
Eurofins genomics (Ebersberg, Germany). PCR was
performed in an automated thermocycler GeneAmp®
PCR System 2400 (Perkin-Elmer, Norwalk, USA) with
GoTaq® G2 Flexi DNA Polymerase Kit (Promega Cor-
poration, USA). Reactions were carried out in 0.2 mL
thin-walled PCR tubes, as described by Ryskaliyeva et
al. [3], using the following PCR cycling conditions:
denaturation of cDNA template at 94 °C for 2 min,
35 cycles at 94 °C for 45 s (denaturation), 58 °C for 30
s (annealing) and 72 °C for 1 min (extension), with a
final extension step of 5 min at 72 °C. Sequencing of
PCR fragments was performed using PCR primers
from both strands, according to the Sanger method
by Eurofins MWG GmbH (Ebersberg, Germany).
1D sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and protein identification by
LC-MS/MS analysis
Both major and low-abundance proteins resolved by
SDS-PAGE were identified by tandem mass analysis
(LC-MS/MS) after excision of the relevant bands from
the gel and trypsin digestion [28]. The SDS-PAGE con-
ditions was that from Laemmli [3, 27].
LC-ESI-MS
Fractionation of camel milk proteins and determination
of their molecular masses were performed by coupling
RP-HPLC to ESI-MS (micrOTOF™ II focus ESI-TOF
mass spectrometer; Bruker Daltonics) as described [3].
Clarified milk samples (25 μL) were directly injected
onto a Biodiscovery C5 reverse phase column (300 Å
pore size, 3 μm, 150 × 2.1 mm; Supelco, France). Eluted
proteins were detected by UV-absorbance at 214 nm and
the effluent directly introduced to the mass spectrom-
eter. Positive ion mode was used, and mass scans were
acquired over a mass-to-charge ratio (m/z) ranging be-
tween 600 and 3000 Da [3].
Results
Nucleotide sequence of camel WAP cDNA
Using the rabbit and rodents WAP encoding gene se-
quences as references, we searched for the expected
fourth exon of the WAP gene in the camel genome se-
quence (NCBI, LOC105095719). A pair of primers
(Table 1) was thus designed, in the first exon upstream
the coding sequence (forward) and overlapping the
downstream putative AATAAA polyA signal (reverse),
to amplify a cDNA fragment that was subsequently se-
quenced. The cDNA sequence of camel WAP thus ob-
tained and given at Fig. 2, consists of 563 nucleotides
encoding a 136 aa polypeptide of Mr 14,510.72 Da, in-
cluding the signal peptide. The molecular mass of the
corresponding mature protein is: 12,564.32 Da.
Identification and characterization of a new WAP genetic
variant in Bactrian camel milk
LC-ESI-MS analysis of a Bactrian camel milk from the
Shymkent region (Fig. 3), revealed the presence, in peak
III (Table 2), of two molecular masses differing by 80 Da
(one phosphate group) 12,596 Da and 12,676 Da, besides
the cognate WAP (12,564 Da and 12, 644 Da). Such a re-
sult and the small mass difference (32 Da) strongly sug-
gested the existence of a novel WAP genetic variant,
which had not been described so far in camels.
Nucleotide sequences of two unrelated individuals (in-
cluding the Bactrian camel from the Shymkent region)
were compared across the complete coding sequence of
the camel WAP cDNA, in both directions. PCR yielded
a fragment of the expected length (ca. 560 bp) for a
complete mRNA open reading frame of 408 bp, demon-
strating that the primary transcript was correctly spliced.
However, examining the nucleotide sequence manually,
a transition G/A may be easily noticed (Fig. 4), leading
to the fourth codon change (GTG/ATG) of exon 2, con-
firmed by the reverse complement sequence. This single
base substitution corresponds to a V/M amino acid sub-
stitution in position 12 of the mature protein, in agree-
ment with the mass difference of 32 Da (V12M, 99 Da
= > 131 Da), found between WAP variants detected in
LC-ESI-MS. We propose to name the camel WAP (V12)
described by Beg et al. [9] as variant A and the newly
identified variant (M12) as variant B. Consequently,
Table 1 Primers used to amplify the cDNA and gDNA target of the WAP gene
Position Primer Sequence 5′- > 3′ nta Amplicon
sizes
Tm, oC
cDNA 5’-UTR Forward ATCTGTCACCTGCCTGCCACCTG 23 557 66
3’-UTR Reverse TGAAGCTGAGTGGGTTTTTATTAGC 25 60
gDNA intron 2 Forward CAGCTGAGGCTGGCCCGCCTC 21 561 70
intron 3 Reverse GCTAGTCTGACACCCTCTCTCTA 23 62
anucleotides
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Fig. 2 Nucleotide sequence of camel WAP cDNA. Primer pairs used for PCR and cDNA sequencing are highlighted in green. Start and stop
codons are highlighted in fuchsia. AA residues encoded by triplet codons are bolded and in blue. The coding sequence and non-coding
sequences are highlighted in cyan and grey, respectively
A
C
B
Fig. 3 Milk protein profiling by LC-ESI-MS of a Bactrian camel milk from the Shymkent region. Eleven major milk protein fractions were identified
from RP-HPLC profile (3.A) in the following order: glycosylated κ-CN A and B (I), non-glycosylated κ-CN A and B (II), WAP (III), shorter (Δex16 and
13′) + short (Δex16) isoforms of αs1-CN A and C (IV and V), α-LAC + αs1-CN A and C + (VI), αs2-CN* (VII), PGRP + αs2-CN* (VIII), LPO/CSA (IX), β-CN A
and B (X) and γ2-CN A and B (XI). Multicharged-ions spectrum from compounds contained in fraction III (3.B). After deconvolution (3.C) the
spectrum shows the presence of cognate camel WAP A-0P (12,546 Da) and 1P (12,644 Da) indicated in black, and molecular masses
corresponding to a new WAP variant (named B) without (12,596 Da) and with (12,676 Da) one phosphate group, indicated in red. *Splicing
variants of αs2-CN with different phosphorylation levels (Ryskaliyeva et al., submitted)
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molecular masses observed by LC-ESI-MS (12,596 Da,
12,676 Da) precisely correspond to unphosphorylated
and phosphorylated (1P) isoforms of WAP variant B, re-
spectively. This B variant which was found in only one
(Bactrian) of the 30 camel milk samples analyzed in
LC-ESI-MS, at the heterozygous state, appeared there-
fore to be rare in the Kazakh population. As far as vari-
ant A is concerned, the unphosphorylated isoform seems
to be prevalent, with relative proportions between
unphosphorylated and phosphorylated protein ranging
between 70/30 and 55/45, whereas the phosphorylated
isoform is predominant (40/60) with the Bactrian camel
heterozygous A/B.
Camel WAP may exist as two isoforms differing in size
LC-MS/MS implemented to confirm the identification
of major camel milk proteins [3] revealed the existence
of two WAP isoforms. Indeed, two tryptic peptides:
SCTVPLMVSSPEPVLK and SCTVPLMEPVLK identify-
ing camel WAP and differentiating in the presence or
absence of the VSSP tetrapeptide (Table 3) were found
in four of the eight individuals analyzed, belonging to
the three camel species. However, the amount of the iso-
form lacking the tetrapeptide VSSP appeared too weak
(1 spectrum vs 10 spectra with VSSP) to be detected by
LC-ESI-MS that is less sensitive than LC-MS/MS.
Discussion
Here we provide the complete camel WAP mRNA se-
quence (408 nucleotides open reading frame) that en-
codes a N-terminal signal peptide of 19 aa residues and
a mature protein of 117 aa residues, of which the mo-
lecular mass is 12,564 Da, and we report the occurrence
in C. bactrianus from Kazakhstan of a WAP genetic
variant, exhibiting a molecular mass of 12,596 Da
(unphosphorylated isoform). cDNA sequencing revealed
a transition G/A, which modifies an amino acid residue
of the mature protein (V12M), accounting for the mass
difference (32 Da) observed between this new genetic
variant and the originally described variant [9].
Camel WAP is phosphorylated
Camel WAP contains five potential phosphorylation
sites (S-X-A code) per molecule (S17, S18, S19, S58, and
S87), meanwhile rat WAP has only three potential phos-
phorylation sites [29]. Whereas rat WAP is phosphory-
lated, it was reported that mouse WAP is apparently
non-phosphorylated [8]. From mass data, it is clear that
only one site is phosphorylated in camel WAP. Given
the extremely constrained and compact structure of the
molecule with 8 S-S bridges, essential for folding and
functionality of the protein, it is very likely that S58
which is located within the additional sequence connect-
ing the two 4-DSC domains, is the only one seryl residue
which is alternatively phosphorylated in camel. There-
fore, the other potential phosphorylation sites, namely
S17, S18, S19 and S87, should not be phosphorylated.
Indeed, WAP contains 16 cysteinyl (C) residues, all of
which being involved in disulfide bridges. C residues ap-
pear in unique arrangements, divided into two domains.
Camel WAP consists of two 4-DSC domains, which are
located between aa residues 9 and 55 (DI) and 64 and
111 (DIIA). Each domain begins with a six aa WAP
motif (9GQAVCP14 and 64KDGRCP69), containing the
first C residue of the 8 found in the domain.
Table 2 Identification of WAP from molecular mass determination using LC-ESI-MS of a clarified Bactrian milk
Peak Ret.Time, (min) Observed Mr (Da) Theoretical Mr (Da) Protein description UniProt accession Intensity
III 24.31 12,564 12,564 WAP variant A, 0P P09837 896
12,596 n/a WAP variant B, 0P n/a 652
12,644 WAP variant A, 1P 951
12,677 WAP variant B, 1P 1059
n/a not applicable
Fig. 4 Partial sequence of WAP cDNA from C. bactrianus from
Shymkent region. Nucleotides arising by manual reading, as G/A and
C/T transitions, in forward (F) and reverse (R) sequences, respectively,
are pointed out by vertical red arrows Nucleotides are clustered by
three (codon) corresponding to aa residues (below codons in the
forward sequence)
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The usage of an unlikely intron cryptic splice site is
responsible for the insertion of 4 amino acid residues in
the major camel WAP isoform
Camel WAP shows the higher sequence identity at the aa
level (76%) to porcine WAP and much lower aa sequence
identities to the WAP from dog (65%), rabbit (51%), rat
(40%) and mouse (39%). The comparison of camel WAP
sequence with that of the other 5 eutherian species in
which the WAP gene is expressed (Sus scrofa, Canis famil-
iaris, Oryctolagus cuniculus, Rattus norvegicus and Mus
musculus), shows a 4 aa residues (56VSSP59) insertion in
the camel polypeptide chain at the beginning of the sec-
ond 4-DSC domain (Fig. 1). From the Camel dromedarius
gene sequence (GenBank LOC105095719) this appears to
be the consequence of the usage of an unlikely intron
cryptic splice site extending camel exon 3 on its 5′ side by
12-nucleotides, whereas in the other 5 species the canonic
3′ end of intron 2 is used (Fig. 5). Indeed, there are two
potential intron donor splice sites responding to all
requirements of splicing recognition signal: CCCG
GCCAG│TCTCTTCCCCAG│AGCCTGTCCTG (ver-
tical bars materializing possible intron end recognition
sites). Paradoxically it is the weakest site (CCCGGCCAG),
with two purine residues (GG) interrupting the polypyri-
midine tract, that is preferentially used by the splicing ma-
chinery. We confirmed this sequence, by sequencing
a 580-bp fragment amplified from genomic DNA
encompassing integrally exon 4 and flanking intron
sequences (Fig. 5).
Alternative pre-mRNA splicing generates multiple
protein isoforms from a single gene. Leading to a shorter
or longer peptide chain, a non-allelic exon-skipping
event may occur during the course of the pre-mRNA
splicing. It is thought to be provoked by the weakness
(unperfected complementarities between splice site sig-
nals and corresponding small ribonuclear protein parti-
cles that make up the spliceosome) in the consensus
sequences, either at the 5′ and/or 3′ splice junctions or
at the branch point, or both [30]. As far as camel WAP
is concerned, even though cDNA sequencing allowed
characterizing a single transcript we could not exclude
the existence of a non-allelic short isoform of camel
WAP, encoded by a shorter mRNA arising from the
usage, as in the other species, of the canonic 3′ splice
site (TCTCTTCCCCAG), which is indeed strongly sug-
gested by the results of LC-MS/MS analyses.
Intron 3 of camel WAP gene is a GC-AG intron type
During the maturation process of pre-mRNA, introns
are precisely removed by a large ribonucleoprotein
complex: the spliceosome. This splicing step requires
splice signals at the 5′ and the 3′ ends of the intron to
be removed and a branch point [31]. In their vast ma-
jority, introns begin with the standard form
Table 3 Sequences of WAP tryptic peptides identified by LC-MS/MS in the milk of a C. bactrianus
ID UniProt
accession
Species Peptide sequence aa residue Mr Spectra
Start Stop
1 P09837 C. dromedarius LAPALSLPGQAVCPELSSSEDNACIISCVNDESCPQGTK 1 39 4174.90 1
2 P09837 C. dromedarius LSLPGQAVCPELSSSEDNACIISCVNDESCPQGTK 5 39 3822.69 1
3 P09837 C. dromedarius IISCVNDESCPQGTK 25 39 1707.77 1
4 P09837 C. dromedarius VNDESCPQGTK 29 39 1234.54 2
5 P09837 C. dromedarius SCTVPLMVSSPEPVLK 49 64 1743.90 6
6 P09837 C. dromedarius SCTVPLMVSSPEPVLKDGR 49 67 2072.05 3
7 P09837 C. dromedarius PLMVSSPEPVLKDGR 53 67 1624.87 1
8 P09837 C. dromedarius DGRCPWVQTPLTAK 65 78 1628.82 1
9 P09837 C. dromedarius CPWVQTPLTAK 68 78 1300.67 11
10 P09837 C. dromedarius HCLEKNDCSR 79 88 1318.56 2
11 P09837 C. dromedarius HCLEKNDCSRDDQCEGNK 79 96 2264.91 1
12 P09837 C. dromedarius HCLEKNDCSRDDQCEGNKK 79 97 2393.00 1
13 P09837 C. dromedarius KCCFSSCAMR 97 106 1322.51 1
14 P09837 C. dromedarius CCFSSCAMR 98 106 1161.39 1
15 P09837 C. dromedarius CLDPVTEDSFQ 107 117 1310.56 13
16 S9XKL5 C. ferus SCTVPLMEPVLK 130 141 1389.71 1
The table is classified by the start aa residues from the N-terminal sequence. Obtained data matches against UniprotKB taxonomy cetartiodactyla (SwissProt +
Trembl) database. Molecular masses (Mr) of peptides are expressed in Da. Spectra indicates the number of spectra permitting the identification of peptides.
Charge corresponds to the number of charges (z) of multi-charged ions precursors having given the MS/MS spectra. Tryptic peptides connecting the DI and DIIa
domains of the protein, including or not the tetrapeptide VSSP, are in bold. Numbering of the C. ferus peptide sequence is from KB016488 Genomic
DNA Translation
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dinucleotide GT at the 5′ splice site and terminate with
the dinucleotide AG at the 3′ splice site, so-called
GT-AG introns. This rule hold in most cases, however
some exceptions have been found [32]. For example, at
the 5′ terminus of a few introns, a dinucleotide GC can
be occasionally found [33]. Based on the data sets de-
rived from annotated gene structures, it has been re-
ported that GC donor sites account for less than 1% of
annotated donor sites and possess a strong consensus
sequence [33]. GC-AG introns are processed by the
same splicing pathway (U2-type spliceosome) as con-
ventional GT-AG introns [34]. GC-AG introns works
in balance with alternative GT splice donor and uses al-
ternative donor and acceptor splice sites, and lack a
reasonable poly pyrimidine tract [33]. In humans, about
0.7% of GC-AG introns are involved in regulated spli-
cing [35]. In Caenorhabditis elegans, experiments indi-
cate that the conserved C at the + 2 position of the
tenth intron of the let-2 gene is essential for develop-
mentally regulated alternative splicing [35]. In camel
WAP gene, the C might allow the splice donor to
function as a very weak splice site that works in balance
with an alternative GT splice donor. In this respect, the
only possibility would be the use of the GTCAC site, 7
nt upstream of the GCGAG. Such an assumption would
modify the 3′ acceptor splice site of intron 3 to main-
tain a frame of reading in phase and to cause the loss
of 3 aa residues: V and T (5′ side of intron 3) and E (3′
side of intron 3) in the camel WAP sequence. The
C-terminal sequence of the protein described by Beg
and co-workers [9] terminates with the peptide se-
quence DPVTEDSFQ. The protein sequence deduced
from our cDNA sequencing, in accordance with the
molecular mass determined from LC-MS, terminates
with the identical DPVTEDSFQ peptide sequence. The
usage of the postulated alternative GT donor splice site
cannot be excluded. However, then to preserve the
reading frame in phase, the upstream intron should end
with the second AG (284,453/4) highlighted in yellow
at Fig. 5. However, we were unable to detect a DPDSFQ
C-terminal, as well in LC-MS/MS as through cDNA se-
quencing. Surprisingly, in WAP gene, available in
Fig. 5 Complete sequence of C. dromedarius WAP gene available in GenBank (NCBI, LOC105095719). Primer pairs used for PCR and gDNA
sequencing are highlighted in green. Introns and intergenic sequences are in italics. Intron donor and acceptor sites are bolded. The effective
intron donor site (GCAAG) is highlighted in fuchsia. The reading frame in WAP gene is preserved through a 2–1 exon phase (nucleotides involved
at the 5′- and 3′-ends are highlighted in yellow). Triplet codons encoding aa are given in blue and encoding specific to camel WAP tetrapeptide
VSSP in red. The wrong protein sequence is indicated in grey and polyA site (AATAAA) is in purple. Stop codons are indicated with *: the correct
one is in blue and “algorithm” predicted is in grey
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GenBank (NCBI, LOC105095719) exon 3 is prolonged
with 99 nucleotides encoding 33 aa residues until the
occurrence of a potential TAA stop codon, which
would make exon 4 ineffective. From our results, in
agreement with the protein structure first reported [9]
and our results, the use of this GC donor site is more
than likely. Especially since it was reported that alterna-
tive GC-AG introns show a compensatory effect in
terms of a dramatic increase in consensus at the donor
(AG-GCAAG) as well as at the polyYx(C/T)AG-G ac-
ceptor exon positions [33].
Conclusions
In this study, combining proven proteomic and molecu-
lar biology approaches, three main findings in respect to
camel WAP are provided. The first one is the identifica-
tion of a new genetic variant (B), originating from a
transition G = > A, leading to a codon change (GTG/
ATG) in the nucleotide sequence of a Bactrian cDNA,
which modifies a single amino acid residue at position
12 of the mature protein (V12M). The second is the de-
tection of two transcripts coding for camel WAP, of
which the major one is arising from an improper and
unusual processing of a unique pre-mRNA, due to a
cryptic splice site usage. This phenomenon leads to the
gain or loss of 4 amino acid residues (56VSSP59), of
which one serine residue (in bold and underlined) is al-
ternatively phosphorylated. Such a genetic polymorph-
ism and splicing events generate a molecular sequence
diversity that might account for physiochemical proper-
ties of camel WAP that would be quite different, and
might contribute unique properties to camel milk. Fi-
nally, we report here the occurrence of a GC-AG
intron-type (intron 3) in camel gene encoding WAP,
showing a compensatory effect in terms of a dramatic
increase in consensus at the acceptor exon position.
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